A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2011
12/21/2011	CN101732614B 一种治疗泌尿系感染的中药 An herbal treatment of urinary tract infections
12/21/2011	CN101723958B 头孢地嗪钠药物及制备方法 Cefodizime drugs and preparation methods
12/21/2011	CN101716199B 一种从木芙蓉叶中提取黄酮类化合物的方法 A method of extracting flavonoids from hibiscus leaves
12/21/2011	CN101690785B 一种抑菌洗液及其制备方法 An antibacterial lotion and its preparation method
12/21/2011	CN101633663B 一种青霉素类钠、钾盐的合成方法 Synthesis of sodium penicillin class, potassium
12/21/2011	CN101606977B 一种丁香叶总环烯醚萜苷的制备方法及用途 One kind of clove leaf total iridoid glycosides preparation and use
12/21/2011	CN101602795B 环六脂肽胺类抗真菌化合物及其盐类和制备方法 Cyclic six antifungal lipopeptide amine compounds and salts thereof and methods for preparing
12/21/2011	CN101597327B 一种o型口蹄疫病毒抗原表位的分子模拟肽及其用途 One kind o-mouth disease virus epitope peptide molecular modeling and their use
12/21/2011	CN101530481B 一种抗鸽痘中药组合物及其口服液的制备方法 An anti-pigeon pox composition and preparation of oral liquid medicine
12/21/2011	CN101524411B 大容量苦黄注射液及其制备方法 Large capacity Kuhuang injection and its preparation method
12/21/2011	CN101506061B 抑制食物病原体的活性包装材料、获得其的方法及其在抑制病原体中的应用 Inhibit food pathogens active packaging material, its method of obtaining and inhibiting pathogen Application
12/21/2011	CN101492650B 一种抗猪链球菌细菌素及其生产方法与专用菌株 An anti-Streptococcus suis bacteriocin and its production method and special strain
12/21/2011	CN101475630B 牛蛙抗菌肽temporin-La及其基因和在制药中的应用 Bullfrog temporin-La antimicrobial peptide gene and its application in pharmacy
12/21/2011	CN101457222B 用于抑制和杀灭耐药性细菌的双链小分子干扰核酸及其组合 Double-stranded small molecules used to inhibit and kill bacterial resistance interfering nucleic acid, and combinations thereof
12/21/2011	CN101406529B 一种治疗带状疱疹的药物 A treatment for shingles drug
12/21/2011	CN101313962B 一种治疗脓疱疮的汤剂药物 A treatment for impetigo drug decoction
12/21/2011	CN101244267B 一种增强微生物疫苗免疫原性的免疫制剂 An enhanced microbial vaccine immunogenicity immune agents
12/21/2011	CN101084901B 一种葡萄球菌抑制剂 One kind of staph inhibitor
12/21/2011	CN101081227B 甘草酸二铵的组合物 The composition of glycyrrhizin diammonium
12/20/2011	US8080666 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
12/20/2011	US8080641 Process for the production of multiple cross-linked hyaluronic acid derivatives
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	US8080635 Non-functional P2X7 receptor
12/20/2011	US8080633 Antiviral compositions comprising a multiple branched peptide construct containing human CD38 leukocyte surface antigen polypeptides
12/20/2011	US8080554 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
12/20/2011	US8080551 HIV inhibiting pyrimidines derivatives
12/20/2011	US8080525 Peptide compositions and their use against the hepatitis C virus
12/20/2011	US8080431 Nanoparticles
12/20/2011	US8080388 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/20/2011	US8080258 Antimicrobial agent
12/20/2011	CA2535664C Disinfecting and sanitizing article for hands and skin and hard surfaces
12/20/2011	CA2524665C Drug delivery system
12/20/2011	CA2447450C Corona-virus-like particles comprising functionally deleted genomes
12/20/2011	CA2381143C Dendrimer-photosensitizer complexes for medical applications
12/20/2011	CA2362454C Viral vectors and viral vaccines based on recombinant porcine adenoviruses
12/20/2011	CA2252375C Nucleic acid vaccination for parvoviral infections
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156694A2 Enrichment and purification of infectious prion proteins
12/15/2011	WO2011156626A1 Antimicrobial agents
12/15/2011	WO2011156416A1 Topical antiviral formulations for prevention of transmission of hsv-2
12/15/2011	WO2011156337A2 Macrocyclic hepatitis c serine protease inhibitors
12/15/2011	WO2011155898A1 New antiviral compounds
12/15/2011	WO2011155887A1 Kit for the treatment of onychomycosis by nitric oxide
12/15/2011	WO2011155727A2 Method for preventing and treating infection caused by salmonella choleraesuis or salmonella dublin
12/15/2011	WO2011154871A1 Hepatitis c virus inhibitors
12/15/2011	WO2011154772A1 Oral veterinary composition for salmonids, comprising 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide and use thereof for the treatment of infectious salmon anaemia (isa) in salmonids
12/15/2011	WO2011154771A1 Use of 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anaemia (isa) in salmonids
12/15/2011	WO2011154755A1 Nanostructured atorvastatin, its pharmaceutically acceptable salts and compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
12/15/2011	WO2011154585A1 Use of a novel alpha-proteobacteria for quorum quenching
12/15/2011	WO2011154580A1 Novel cxcr4 inhibitors as anti-hiv agents
12/15/2011	WO2011154574A1 Camptothecin derivatives as antitumoural agents
12/15/2011	WO2011154298A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES
12/15/2011	WO2011154007A1 Bacteriophages for use against bacterial infections
12/15/2011	WO2011153959A1 Conjugates of flu virus m2 or ha2 fragments and protein carriers, and pharmaceutical use thereof
12/15/2011	WO2011153763A1 Mixture of t cell immune balance peptides
12/15/2011	WO2011153647A1 Pharmaceutical composition with olive extract (hydroxytyrosol) and hop extract (xanthohumol) for intranasal application
12/15/2011	WO2011153588A1 Viral polymerase inhibitors
12/15/2011	WO2011131208A4 Bivalent enterotoxemia vaccine for veterinary use
12/15/2011	WO2011130878A9 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
12/15/2011	WO2011124986A3 Polyol modified aminoglycoside-lipid conjugates
12/15/2011	WO2011113013A3 Methods and compositions for treating viral or virally-induced conditions
12/15/2011	WO2011093832A3 Stable efervescent formulations comprising cefaclor
12/15/2011	WO2011091376A3 Immunogenic influenza composition
12/15/2011	WO2011091027A3 Recombinant live attenuated foot-and-mouth disease (fmd) vaccine containing mutations in the l protein coding region
12/15/2011	US20110306655 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306644 Metalloenzyme inhibitor compounds
12/15/2011	US20110306634 Amorphous Salt of a Macrocyclic Inhibitor of HCV
12/15/2011	US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011	US20110306611 Transcription factor modulating compounds and methods of use thereof
12/15/2011	US20110306610 9-substituted 8-oxoadenine compound
12/15/2011	US20110306602 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/15/2011	US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	US20110306585 Metal Complexes of N-Heterocyclic Carbenes
12/15/2011	US20110306584 Porphyrin Catalysts and Methods of Use Thereof
12/15/2011	US20110306578 Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections
12/15/2011	US20110306576 Compounds and methods relating thereto
12/15/2011	US20110306574 Inhibitors of f18+ e coli binding
12/15/2011	US20110306573 Nucleoside derivatives as inhibitors of viral polymerases
12/15/2011	US20110306566 Topical skin treatment kits
12/15/2011	US20110306560 Boronic ester and acid compounds, synthesis and uses
12/15/2011	US20110306545 Novel peptides for wound healing
12/15/2011	US20110306544 Methods and formulations for increasing intestinal function
12/15/2011	US20110306541 Methods for treating hcv
12/15/2011	US20110306539 Process for making particles for delivery of drug nanoparticles
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110306018 Methods For Improving Pregnancy Outcomes
12/15/2011	US20110305774 Treatment of retroviral reservoirs exploiting oxidative stress
12/15/2011	US20110305770 Releasable polymeric lipids for nucleic acids delivery system
12/15/2011	US20110305769 Branched cationic lipids for nucleic acids delivery system
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305765 Preparation and methodology of silk fibroin nanoparticles
12/15/2011	US20110305763 Lantibiotics and uses thereof
12/15/2011	US20110305755 Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
12/15/2011	US20110305751 Glutathione-based drug delivery system
12/15/2011	US20110305749 HIV-1 Envelope Polypeptides for HIV Vaccine
12/15/2011	US20110305745 Pollulan regenerative matrix
12/15/2011	US20110305743 Ocular implant made by a double extrusion process
12/15/2011	US20110305735 Skin antiaging treatment
12/15/2011	US20110305731 Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarries

1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 1798